Skip to main content

Table 1 General characteristics of cases and controls

From: Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population

  CAD Controls P
Number of subjects 600 600  
Age (years), mean(SD) 57.3 ± 10.8 56.9 ± 10.1 0.51
Gender (Male/Female) 486/114 462/138 0.09
Smoking status (Ever/Never) 192/408 98/502 <0.001
Family history (Positive/Negative) 98/502 77/523 0.09
Hypertension (Positive/Negative) 305/295 280/320 0.15
Diabetes (Positive/Negative) 156/444 78/522 <0.001
Obesity (Positive/Negative) 176/424 85/515 <0.001
Hyperlipidemia (Positive/Negative) 188/412 92/508 <0.001
TG (mg/dL) 180.5 ± 92.3 151.7 ± 79.4 <0.001
TC (mg/dL) 202.1 ± 60.2 189.6 ± 47.9 <0.001
HDL-C (mg/dL) 37.4 ± 11.3 39.5 ± 12.4 0.002
LDL-C (mg/dL) 124.8 ± 49.8 116.7 ± 35.4 0.001
VLDL-C (mg/dL) 39.8 ± 23.7 32.7 ± 19.5 <0.001
ApoA1 (mg/dL) 127.3 ± 23.7 126.8 ± 22.9 0.71
ApoB (mg/dL) 90.6 ± 28.7 89.7 ± 24.5 0.56
  1. Abbreviations: CAD coronary artery disease, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol VLDL-C very-low-density lipoprotein cholesterol, Apo apolipoprotein.